Daventry Group’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Daventry Group's AGL Position: Q2 2024 in Review
Daventry Group sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 70,010 shares — an estimated $10.7M sold.
Daventry Group first reported a position in AGL in Q4 2023 and held it in 2 quarters. The position peaked at $18.9M in Q4 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.
- Daventry Group reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
- Daventry Group sold 70,010 Agilon Health shares in Q2 2024, an estimated $10.7M.
- Daventry Group first reported a position in Agilon Health in Q4 2023 and held it in 2 quarters.
- Daventry Group's Agilon Health position peaked at $18.9M in Q4 2023.
- 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.
Based on Daventry Group's 13F filing for Q2 2024, filed 14 Aug 2024.